mitomycin has been researched along with Peritoneal Diseases in 2 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Peritoneal Diseases: Pathological processes involving the PERITONEUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mitomycin C (MMC) is a powerful anti-bacterial, anti-fungal and anti-tumor antibiotic, often active against multidrug resistant cells." | 1.43 | Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity. ( Amitay, Y; Gabizon, A; Ohana, P; Patil, Y; Shmeeda, H, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patil, Y | 1 |
| Amitay, Y | 1 |
| Ohana, P | 1 |
| Shmeeda, H | 1 |
| Gabizon, A | 1 |
| Cubukçu, A | 1 |
| Alponat, A | 1 |
| Gönüllü, NN | 1 |
2 other studies available for mitomycin and Peritoneal Diseases
| Article | Year |
|---|---|
Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Cholesterol; Female; Folic Ac | 2016 |
Mitomycin-C prevents reformation of intra-abdominal adhesions after adhesiolysis.
Topics: Alkylating Agents; Animals; Female; Mitomycin; Peritoneal Diseases; Postoperative Complications; Rat | 2002 |